Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

AI test could predict effective cancer drug combinations in less than two days

April 4, 2022 Sales and Marketing

Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in …
News

FDA accepts Dupixent for Priority Review in patients 12+ with eosinophilic esophagitis

April 4, 2022 Sales and Marketing

The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 …
News

New centre targets ‘undruggable’ cancers

April 4, 2022 Sales and Marketing

The new Centre for Protein Degradation has been launched, made possible by a £9 million donation to The Institute of …
News

COVID-19 vaccines now available for five to 11-year olds in England

April 4, 2022 Sales and Marketing

Parents and carers of five to 11-year olds in England can now book a low-dose COVID-19 vaccine for their children. …
News

NICE does not recommend icosapent ethyl for prevention of cardiovascular events

March 28, 2022 Sales and Marketing

NICE has published further draft guidance for public consultation which does not recommend VAZKEPA (icosapent ethyl) for reducing the risk …
News

FDA approve oral solution for rare childhood epilepsy

March 28, 2022 Sales and Marketing

UCB has announced that FINTEPLA® (fenfluramine) oral solution CIV has been approved by the FDA for the treatment of seizures …
News

EMA review first novel gene therapy candidate for haemophilia B

March 28, 2022 Sales and Marketing

CSL Behring has today announced that the EMA has accepted the Marketing Authorising Application for etranacogene dezaparvovec (EtranaDez), under its …
News

Pregnant women to receive life-saving pre-eclampsia check on NHS

March 28, 2022 Sales and Marketing

A life-saving blood test that can help diagnose suspected preterm pre-eclampsia has been recommended by NICE, and this is to …
News
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
Appointment

FDA approval for first in class immunotherapy for advanced melanoma

March 21, 2022 Sales and Marketing

The FDA has approved Bristol-Myers Squibb’s Opdualag (nivolumab and relatlimab-rmbw), the first drug in a new class of cancer immunotherapies, …
News

Spring COVID-19 booster launches for over-75s and high risk in England

March 21, 2022 Sales and Marketing

Those aged 75 and over, alongside residents in care homes and those with weakened immune systems, can now book an …
News

UCLA’s HIV prevention and treatment centre receives $7.5 million NIH grant

March 21, 2022 Sales and Marketing

The National Institute of Mental Health has renewed its support for UCLA’s collaborative Centre for HIV Identification, Prevention and Treatment …
News

Merck’s Keytruda delivers reduced risk of death in adjuvant NSCLC

March 21, 2022 Sales and Marketing

Merck has announced positive results from its Phase III trial into Keytruda for non-small cell lung cancer. The KEYNOTE-091 study …
News

CanSinoBIO’s Convidecia effective as booster against Omicron

March 14, 2022 Sales and Marketing

According to an academic paper on the efficacy of CanSinoBIO’s recombinant COVID-19 vaccine, published on medRxiv, the vaccine is effective …
News
e-6olmfwuay74lr

UK Health Secretary: rise in COVID-19 cases ‘expected’

March 14, 2022 Sales and Marketing

A surge in COVID-19 cases was to be “expected”, following the ease of pandemic restrictions in England, insisted UK Health …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025